JustRaised: Funded Startup Founders Databasejustraised
Phrontline Biopharma logo

Phrontline Biopharma

Phrontline Biopharma develops innovative antibody-drug conjugates (ADCs) focused on oncology therapies.

Website Hangzhou, ChinaBiotechnology
Amount raised
$40M
Round
Series A
Date raised
November 13, 2026
Founded
2022
CompanyPhrontline Biopharma
IndustryBiotechnology
LocationHangzhou, China
InvestorsDecheng Capital, Oriza Seed Venture Capital

Founder

  • Tony Chen
    Founder and Chief Executive Officer
    Hangzhou, China

Get new raises like this every week

Free weekly list of newly funded startups and their founders.

Request a custom lead list

About Phrontline Biopharma

Phrontline Biopharma develops innovative antibody-drug conjugates (ADCs) focused on oncology therapies.

How much did Phrontline Biopharma raise?
Phrontline Biopharma raised $40M in a Series A round on November 13, 2026. Investors include Decheng Capital, Oriza Seed Venture Capital.
Who founded Phrontline Biopharma?
Tony Chen founded Phrontline Biopharma in 2022.
Where is Phrontline Biopharma based?
Phrontline Biopharma is based in Hangzhou, China.

Similar funded startups